Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations

Valerie McGuire, A. Felberg, M. Mills, K. L. Ostrow, R. DiCioccio, E. M. John, D. W. West, A. S. Whittemore

Research output: Contribution to journalArticle

Abstract

In the general population, ovarian cancer risk is inversely associated with oral contraceptive use, tubal ligation, and childbearing. Among carriers of BRCA1 gene mutations, the data are conflicting. The authors identified women diagnosed with incident invasive epithelial ovarian cancer in the San Francisco Bay Area of California from March 1997 through July 2001. They compared the contraceptive and reproductive histories of 36 carrier cases and 381 noncarrier cases with those of 568 controls identified by random digit dialing who were frequency matched to cases on age and race/ethnicity. In both carriers and noncarriers, reduced risk was associated with ever use of oral contraceptives (odds ratio = 0.54 (95% confidence interval (CI): 0.26, 1.13) for carriers and 0.55 (95% CI: 0.41, 0.73) for noncarriers), duration of oral contraceptive use (risk reduction per year = 13% (p = 0.01) for carriers and 6% (p < 0.001) for noncarriers), history of tubal ligation (odds ratio = 0.68 (95% CI: 0.25, 1.90) for carriers and 0.65 (95% CI: 0.45, 0.95) for noncarriers), and increasing parity (risk reduction per childbirth = 16% (p = 0.26) for carriers and 24% (p < 0.001) for noncarriers). These data suggest that BRCA1 mutation carriers and noncarriers have similar risk reductions associated with oral contraceptive use, tubal ligation, and parity.

Original languageEnglish (US)
Pages (from-to)613-618
Number of pages6
JournalAmerican journal of epidemiology
Volume160
Issue number7
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Keywords

  • Contraceptives, oral
  • Genes, BRCA1
  • Mutation
  • Ovarian neoplasms
  • Parity
  • Sterilization, tubal

ASJC Scopus subject areas

  • Epidemiology

Fingerprint Dive into the research topics of 'Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations'. Together they form a unique fingerprint.

  • Cite this